Skip to content
Buy This GLP
← Research
Formats

Wegovy Tablet vs Injection: What an Indirect Trial Comparison Found

An analysis compared the 25 mg tablet with the 2.4 mg injection through separate placebo trials. The estimated difference was small and uncertain.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team4 min read
Estimated weight-loss advantage for injectionno difference1.01−1.613.63Nobody was randomized between the two products.Two separate trials, bridged statistically.

Researchers used two placebo trials to estimate a difference between Wegovy tablets and injections [1]. Our guide to oral and injected semaglutide doses explains what each trial measured. No participants were randomly assigned between the two formulations in this analysis.

How the comparison worked

OASIS 4 tested the 25 mg daily tablet against oral placebo. STEP 1 tested the 2.4 mg weekly injection against injectable placebo. Researchers used the placebo arms as a common reference [1]. The analysis depends on how comparable the trials and their participants were.

What the numbers show

The estimated weight-loss difference favored the injection by 1.01 percentage points [1]. The 95% confidence interval ran from −1.61 to 3.63 points. A second analysis assuming adherence favored the injection by 0.55 points, with a 95% confidence interval from −2.25 to 3.35. Both intervals leave room for a small advantage in either direction.

Novo Nordisk, the maker of Wegovy, funded this indirect comparison. A price comparison for GLP-1 pills and injections is useful only when the products and terms are clear. This analysis does not establish therapeutic equivalence or extend to other formulations.

Frequently asked

Did the study compare Wegovy tablets and injections directly?
No. It used placebo arms from two separate trials as a common reference.
How large was the estimated difference?
Weight loss favored injection by 1.01 percentage points. The 95% confidence interval from −1.61 to 3.63 points allows a small advantage in either direction.
Does this establish that the formulations are equivalent?
The study estimates a difference indirectly. Differences between trials still matter, and the authors did not randomize participants between formulations.

Sources

  1. [1] Plotkin M, Ivkovic M, Smith I, Rathor N, Chowdhury R, Hodkinson A (2026). Semaglutide 25 mg Oral Versus Semaglutide 2.4 mg Injectable: An Indirect Treatment Comparison of Weight Loss Outcomes Diabetes, Obesity & Metabolism. PMID 42225300

Where to get it

Price the oral sellers

Switch the desk to tablets and it prices the oral product itself, never a figure borrowed from the same seller's injection page.

Open the price desk →

More in Formats